| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 2.05e-11 | 188 | 34 | 9 | GO:0005201 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 2.49e-06 | 16 | 34 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | calcium ion binding | 3.16e-06 | 749 | 34 | 9 | GO:0005509 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle binding | 3.62e-06 | 18 | 34 | 3 | GO:0030169 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 5.87e-06 | 21 | 34 | 3 | GO:0030228 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 1.28e-05 | 27 | 34 | 3 | GO:0005044 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.29e-05 | 85 | 34 | 4 | GO:0038024 | |
| GeneOntologyMolecularFunction | structural molecule activity | 1.29e-05 | 891 | 34 | 9 | GO:0005198 | |
| GeneOntologyMolecularFunction | lipoprotein particle binding | 2.84e-05 | 35 | 34 | 3 | GO:0071813 | |
| GeneOntologyMolecularFunction | protein-lipid complex binding | 2.84e-05 | 35 | 34 | 3 | GO:0071814 | |
| GeneOntologyMolecularFunction | semaphorin receptor activity | 1.84e-04 | 12 | 34 | 2 | GO:0017154 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | SCARF1 TAS1R1 PLXNA3 ADGRG7 ERBB4 IL22RA2 PLXNC1 EDA2R SORL1 | 3.27e-04 | 1353 | 34 | 9 | GO:0004888 |
| GeneOntologyMolecularFunction | peptidase regulator activity | 9.18e-04 | 257 | 34 | 4 | GO:0061134 | |
| GeneOntologyMolecularFunction | Notch binding | 9.62e-04 | 27 | 34 | 2 | GO:0005112 | |
| GeneOntologyMolecularFunction | growth factor binding | 2.34e-03 | 156 | 34 | 3 | GO:0019838 | |
| GeneOntologyMolecularFunction | integrin binding | 3.24e-03 | 175 | 34 | 3 | GO:0005178 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 3.41e-03 | 51 | 34 | 2 | GO:0043394 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 3.91e-03 | 187 | 34 | 3 | GO:0030414 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 6.86e-03 | 73 | 34 | 2 | GO:0050840 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 1.05e-02 | 268 | 34 | 3 | GO:0005539 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 1.30e-02 | 102 | 34 | 2 | GO:0001540 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 1.73e-02 | 323 | 34 | 3 | GO:1901681 | |
| GeneOntologyBiologicalProcess | axon extension involved in regeneration | 2.63e-05 | 5 | 34 | 2 | GO:0048677 | |
| GeneOntologyBiologicalProcess | positive regulation of axonogenesis | 3.61e-05 | 114 | 34 | 4 | GO:0050772 | |
| GeneOntologyBiologicalProcess | sprouting of injured axon | 3.94e-05 | 6 | 34 | 2 | GO:0048682 | |
| GeneOntologyBiologicalProcess | regeneration | 5.45e-05 | 252 | 34 | 5 | GO:0031099 | |
| GeneOntologyBiologicalProcess | axon extension | 6.99e-05 | 135 | 34 | 4 | GO:0048675 | |
| GeneOntologyBiologicalProcess | regulation of cell migration | 1.11e-04 | 1211 | 34 | 9 | GO:0030334 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | 1.39e-04 | 494 | 34 | 6 | GO:0031346 | |
| GeneOntologyBiologicalProcess | regulation of cell motility | 1.69e-04 | 1280 | 34 | 9 | GO:2000145 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | 1.75e-04 | 515 | 34 | 6 | GO:0050767 | |
| GeneOntologyBiologicalProcess | axon regeneration | 1.99e-04 | 69 | 34 | 3 | GO:0031103 | |
| GeneOntologyBiologicalProcess | regulation of locomotion | 2.22e-04 | 1327 | 34 | 9 | GO:0040012 | |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 2.71e-04 | 192 | 34 | 4 | GO:0050770 | |
| GeneOntologyBiologicalProcess | neuron projection regeneration | 3.20e-04 | 81 | 34 | 3 | GO:0031102 | |
| GeneOntologyBiologicalProcess | positive regulation of axon regeneration | 3.53e-04 | 17 | 34 | 2 | GO:0048680 | |
| GeneOntologyBiologicalProcess | neuron projection extension | 3.61e-04 | 207 | 34 | 4 | GO:1990138 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron projection regeneration | 3.97e-04 | 18 | 34 | 2 | GO:0070572 | |
| GeneOntologyBiologicalProcess | circulatory system development | 4.12e-04 | 1442 | 34 | 9 | GO:0072359 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | 4.41e-04 | 612 | 34 | 6 | GO:0010975 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | 4.93e-04 | 625 | 34 | 6 | GO:0051960 | |
| GeneOntologyBiologicalProcess | axon development | 5.68e-04 | 642 | 34 | 6 | GO:0061564 | |
| GeneOntologyBiologicalProcess | regulation of axon extension | 6.65e-04 | 104 | 34 | 3 | GO:0030516 | |
| GeneOntologyBiologicalProcess | response to axon injury | 6.84e-04 | 105 | 34 | 3 | GO:0048678 | |
| GeneOntologyBiologicalProcess | maintenance of gastrointestinal epithelium | 7.12e-04 | 24 | 34 | 2 | GO:0030277 | |
| GeneOntologyBiologicalProcess | negative regulation of locomotion | 8.30e-04 | 454 | 34 | 5 | GO:0040013 | |
| GeneOntologyBiologicalProcess | vasculature development | 8.73e-04 | 969 | 34 | 7 | GO:0001944 | |
| GeneOntologyBiologicalProcess | cell junction organization | 8.99e-04 | 974 | 34 | 7 | GO:0034330 | |
| GeneOntologyBiologicalProcess | regulation of extent of cell growth | 1.06e-03 | 122 | 34 | 3 | GO:0061387 | |
| GeneOntologyBiologicalProcess | heart development | 1.34e-03 | 757 | 34 | 6 | GO:0007507 | |
| GeneOntologyBiologicalProcess | regulation of smooth muscle cell migration | 1.38e-03 | 134 | 34 | 3 | GO:0014910 | |
| GeneOntologyBiologicalProcess | developmental growth involved in morphogenesis | 1.42e-03 | 299 | 34 | 4 | GO:0060560 | |
| GeneOntologyBiologicalProcess | developmental cell growth | 1.46e-03 | 301 | 34 | 4 | GO:0048588 | |
| GeneOntologyBiologicalProcess | epithelial structure maintenance | 1.60e-03 | 36 | 34 | 2 | GO:0010669 | |
| GeneOntologyCellularComponent | extracellular matrix | LAMB2 EYS LTBP2 EGFL7 ZAN FN1 MEGF6 IGFBP6 MUC2 SSPOP MUC5AC MUC6 FBN3 SVEP1 | 6.11e-13 | 656 | 34 | 14 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | LAMB2 EYS LTBP2 EGFL7 ZAN FN1 MEGF6 IGFBP6 MUC2 SSPOP MUC5AC MUC6 FBN3 SVEP1 | 6.36e-13 | 658 | 34 | 14 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 1.21e-07 | 530 | 34 | 9 | GO:0062023 | |
| GeneOntologyCellularComponent | mucus layer | 7.70e-06 | 3 | 34 | 2 | GO:0070701 | |
| GeneOntologyCellularComponent | semaphorin receptor complex | 1.98e-04 | 13 | 34 | 2 | GO:0002116 | |
| GeneOntologyCellularComponent | Golgi lumen | 7.34e-04 | 109 | 34 | 3 | GO:0005796 | |
| Domain | EGF_1 | SCARF1 LRP1 LAMB2 EYS LTBP2 EGFL7 ZAN FN1 MEGF6 TENM3 DLL4 SSPOP MEGF11 FBN3 SVEP1 WIF1 STAB1 | 2.21e-23 | 255 | 34 | 17 | PS00022 |
| Domain | EGF-like_CS | SCARF1 LRP1 LAMB2 EYS LTBP2 EGFL7 ZAN FN1 MEGF6 TENM3 DLL4 MEGF11 FBN3 SVEP1 SORL1 WIF1 STAB1 | 3.30e-23 | 261 | 34 | 17 | IPR013032 |
| Domain | EGF_2 | SCARF1 LRP1 LAMB2 EYS LTBP2 EGFL7 ZAN MEGF6 TENM3 DLL4 SSPOP MEGF11 FBN3 SVEP1 SORL1 WIF1 STAB1 | 4.30e-23 | 265 | 34 | 17 | PS01186 |
| Domain | EGF_3 | SCARF1 LRP1 EYS LTBP2 EGFL7 ZAN MEGF6 TENM3 DLL4 SSPOP MEGF11 FBN3 SVEP1 SORL1 WIF1 STAB1 | 4.25e-22 | 235 | 34 | 16 | PS50026 |
| Domain | EGF | SCARF1 LRP1 LAMB2 EYS LTBP2 EGFL7 ZAN MEGF6 TENM3 DLL4 MEGF11 FBN3 SVEP1 SORL1 WIF1 STAB1 | 4.25e-22 | 235 | 34 | 16 | SM00181 |
| Domain | EGF-like_dom | SCARF1 LRP1 LAMB2 EYS LTBP2 EGFL7 ZAN MEGF6 TENM3 DLL4 MEGF11 FBN3 SVEP1 SORL1 WIF1 STAB1 | 1.09e-21 | 249 | 34 | 16 | IPR000742 |
| Domain | Growth_fac_rcpt_ | SCARF1 LRP1 LAMB2 EYS ERBB4 LTBP2 EGFL7 MEGF6 IGFBP6 DLL4 FBN3 SVEP1 STAB1 | 4.62e-19 | 156 | 34 | 13 | IPR009030 |
| Domain | EGF_extracell | 6.57e-18 | 60 | 34 | 10 | IPR013111 | |
| Domain | EGF_2 | 6.57e-18 | 60 | 34 | 10 | PF07974 | |
| Domain | EGF | 1.55e-14 | 126 | 34 | 10 | PF00008 | |
| Domain | EGF_CA | 7.34e-13 | 122 | 34 | 9 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 8.52e-13 | 124 | 34 | 9 | IPR001881 | |
| Domain | ASX_HYDROXYL | 8.22e-12 | 100 | 34 | 8 | PS00010 | |
| Domain | hEGF | 8.36e-12 | 28 | 34 | 6 | PF12661 | |
| Domain | TIL | 1.15e-11 | 12 | 34 | 5 | PF01826 | |
| Domain | C8 | 1.15e-11 | 12 | 34 | 5 | PF08742 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.32e-11 | 106 | 34 | 8 | IPR000152 | |
| Domain | Unchr_dom_Cys-rich | 1.87e-11 | 13 | 34 | 5 | IPR014853 | |
| Domain | C8 | 1.87e-11 | 13 | 34 | 5 | SM00832 | |
| Domain | TIL_dom | 2.91e-11 | 14 | 34 | 5 | IPR002919 | |
| Domain | VWFD | 6.33e-11 | 16 | 34 | 5 | PS51233 | |
| Domain | VWD | 6.33e-11 | 16 | 34 | 5 | SM00216 | |
| Domain | VWF_type-D | 6.33e-11 | 16 | 34 | 5 | IPR001846 | |
| Domain | VWD | 6.33e-11 | 16 | 34 | 5 | PF00094 | |
| Domain | VWC_out | 1.68e-10 | 19 | 34 | 5 | SM00215 | |
| Domain | EGF_Ca-bd_CS | 3.92e-10 | 97 | 34 | 7 | IPR018097 | |
| Domain | EGF_CA | 4.54e-10 | 99 | 34 | 7 | PS01187 | |
| Domain | Laminin_EGF | 4.59e-09 | 35 | 34 | 5 | PF00053 | |
| Domain | Laminin_EGF | 7.07e-09 | 38 | 34 | 5 | IPR002049 | |
| Domain | EGF_CA | 9.68e-09 | 86 | 34 | 6 | PF07645 | |
| Domain | VWF_dom | 1.19e-08 | 42 | 34 | 5 | IPR001007 | |
| Domain | EMI | 2.14e-08 | 17 | 34 | 4 | PS51041 | |
| Domain | Cys_knot_C | 1.13e-07 | 25 | 34 | 4 | IPR006207 | |
| Domain | CTCK_2 | 1.13e-07 | 25 | 34 | 4 | PS01225 | |
| Domain | EGF_Lam | 4.60e-07 | 35 | 34 | 4 | SM00180 | |
| Domain | VWFC_1 | 5.17e-07 | 36 | 34 | 4 | PS01208 | |
| Domain | VWC | 6.47e-07 | 38 | 34 | 4 | SM00214 | |
| Domain | VWFC_2 | 6.47e-07 | 38 | 34 | 4 | PS50184 | |
| Domain | EMI_domain | 3.04e-06 | 16 | 34 | 3 | IPR011489 | |
| Domain | CTCK_1 | 4.41e-06 | 18 | 34 | 3 | PS01185 | |
| Domain | CT | 8.29e-06 | 22 | 34 | 3 | SM00041 | |
| Domain | PET | 4.80e-05 | 6 | 34 | 2 | PF06297 | |
| Domain | PET | 4.80e-05 | 6 | 34 | 2 | PS51303 | |
| Domain | WxxW_domain | 4.80e-05 | 6 | 34 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 4.80e-05 | 6 | 34 | 2 | PF13330 | |
| Domain | PET_domain | 4.80e-05 | 6 | 34 | 2 | IPR010442 | |
| Domain | - | 4.82e-05 | 39 | 34 | 3 | 2.120.10.30 | |
| Domain | LDLR_class-A_CS | 5.20e-05 | 40 | 34 | 3 | IPR023415 | |
| Domain | TB | 6.72e-05 | 7 | 34 | 2 | PF00683 | |
| Domain | Ldl_recept_a | 7.42e-05 | 45 | 34 | 3 | PF00057 | |
| Domain | - | 7.93e-05 | 46 | 34 | 3 | 4.10.400.10 | |
| Domain | 6-blade_b-propeller_TolB-like | 7.93e-05 | 46 | 34 | 3 | IPR011042 | |
| Domain | - | 8.95e-05 | 8 | 34 | 2 | 3.90.290.10 | |
| Domain | LDLRA_1 | 9.01e-05 | 48 | 34 | 3 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 9.59e-05 | 49 | 34 | 3 | IPR002172 | |
| Domain | LDLa | 9.59e-05 | 49 | 34 | 3 | SM00192 | |
| Domain | LDLRA_2 | 9.59e-05 | 49 | 34 | 3 | PS50068 | |
| Domain | Plexin_cytopl | 1.15e-04 | 9 | 34 | 2 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 1.15e-04 | 9 | 34 | 2 | IPR013548 | |
| Domain | TB | 1.15e-04 | 9 | 34 | 2 | PS51364 | |
| Domain | TB_dom | 1.15e-04 | 9 | 34 | 2 | IPR017878 | |
| Domain | Plexin | 1.15e-04 | 9 | 34 | 2 | IPR031148 | |
| Domain | - | 1.75e-04 | 11 | 34 | 2 | 2.40.155.10 | |
| Domain | GFP-like | 1.75e-04 | 11 | 34 | 2 | IPR023413 | |
| Domain | Ldl_recept_b | 2.89e-04 | 14 | 34 | 2 | PF00058 | |
| Domain | LDLRB | 2.89e-04 | 14 | 34 | 2 | PS51120 | |
| Domain | LY | 3.33e-04 | 15 | 34 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 3.33e-04 | 15 | 34 | 2 | IPR000033 | |
| Domain | cEGF | 1.02e-03 | 26 | 34 | 2 | IPR026823 | |
| Domain | cEGF | 1.02e-03 | 26 | 34 | 2 | PF12662 | |
| Domain | IPT | 1.10e-03 | 27 | 34 | 2 | SM00429 | |
| Domain | EGF_LAM_2 | 1.36e-03 | 30 | 34 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 1.36e-03 | 30 | 34 | 2 | PS01248 | |
| Domain | TIG | 1.45e-03 | 31 | 34 | 2 | PF01833 | |
| Domain | SEMA | 1.45e-03 | 31 | 34 | 2 | PS51004 | |
| Domain | Sema | 1.45e-03 | 31 | 34 | 2 | SM00630 | |
| Domain | Semap_dom | 1.45e-03 | 31 | 34 | 2 | IPR001627 | |
| Domain | Sema | 1.45e-03 | 31 | 34 | 2 | PF01403 | |
| Domain | Plexin_repeat | 1.54e-03 | 32 | 34 | 2 | IPR002165 | |
| Domain | PSI | 1.54e-03 | 32 | 34 | 2 | PF01437 | |
| Domain | IPT | 1.54e-03 | 32 | 34 | 2 | IPR002909 | |
| Domain | PSI | 2.90e-03 | 44 | 34 | 2 | IPR016201 | |
| Domain | PSI | 3.17e-03 | 46 | 34 | 2 | SM00423 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 5.65e-06 | 21 | 24 | 3 | MM15706 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 3.19e-05 | 109 | 24 | 4 | MM15164 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 3.24e-05 | 37 | 24 | 3 | M27134 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 5.49e-05 | 44 | 24 | 3 | M26969 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.39e-04 | 60 | 24 | 3 | MM15636 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 2.02e-04 | 68 | 24 | 3 | M27303 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 3.29e-04 | 16 | 24 | 2 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 3.72e-04 | 17 | 24 | 2 | M27412 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 4.67e-04 | 19 | 24 | 2 | MM15512 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 5.93e-04 | 98 | 24 | 3 | M27152 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 6.88e-04 | 23 | 24 | 2 | M556 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 8.14e-04 | 25 | 24 | 2 | M39713 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 8.52e-04 | 111 | 24 | 3 | M27416 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 8.81e-04 | 26 | 24 | 2 | M27483 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 1.07e-03 | 120 | 24 | 3 | MM14982 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.17e-03 | 30 | 24 | 2 | M27772 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 1.17e-03 | 30 | 24 | 2 | MM15812 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 1.17e-03 | 30 | 24 | 2 | M39641 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.17e-03 | 30 | 24 | 2 | MM15517 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 1.17e-03 | 124 | 24 | 3 | M27285 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.34e-03 | 32 | 24 | 2 | MM14854 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.53e-03 | 300 | 24 | 4 | M610 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.77e-03 | 143 | 24 | 3 | M27275 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.98e-03 | 39 | 24 | 2 | MM14601 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 2.19e-03 | 41 | 24 | 2 | M27778 | |
| Pathway | PID_UPA_UPAR_PATHWAY | 2.29e-03 | 42 | 24 | 2 | M174 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 2.40e-03 | 43 | 24 | 2 | M39565 | |
| Pathway | PID_PS1_PATHWAY | 2.75e-03 | 46 | 24 | 2 | M70 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 3.37e-03 | 51 | 24 | 2 | MM14967 | |
| Pubmed | 9.34e-10 | 3 | 35 | 3 | 18300795 | ||
| Pubmed | 9.34e-10 | 3 | 35 | 3 | 18825309 | ||
| Pubmed | 3.73e-09 | 4 | 35 | 3 | 33154304 | ||
| Pubmed | 3.73e-09 | 4 | 35 | 3 | 23807779 | ||
| Pubmed | Gastric mucin expression in first-degree relatives of gastric cancer patients. | 3.73e-09 | 4 | 35 | 3 | 24901817 | |
| Pubmed | MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance. | 3.73e-09 | 4 | 35 | 3 | 27298226 | |
| Pubmed | 3.73e-09 | 4 | 35 | 3 | 36367122 | ||
| Pubmed | 3.73e-09 | 4 | 35 | 3 | 17471237 | ||
| Pubmed | 3.73e-09 | 4 | 35 | 3 | 14984930 | ||
| Pubmed | Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus. | 3.73e-09 | 4 | 35 | 3 | 17401217 | |
| Pubmed | 3.73e-09 | 4 | 35 | 3 | 12676567 | ||
| Pubmed | Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells. | 3.73e-09 | 4 | 35 | 3 | 29869461 | |
| Pubmed | 3.73e-09 | 4 | 35 | 3 | 25298197 | ||
| Pubmed | Mucins in neoplastic spectrum of colorectal polyps: can they provide predictions? | 3.73e-09 | 4 | 35 | 3 | 20929551 | |
| Pubmed | 9.32e-09 | 5 | 35 | 3 | 22261707 | ||
| Pubmed | MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer. | 9.32e-09 | 5 | 35 | 3 | 16475027 | |
| Pubmed | 1.62e-08 | 167 | 35 | 6 | 22159717 | ||
| Pubmed | 1.86e-08 | 6 | 35 | 3 | 17982272 | ||
| Pubmed | 1.86e-08 | 6 | 35 | 3 | 19110483 | ||
| Pubmed | 2.14e-08 | 175 | 35 | 6 | 28071719 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 6.90e-08 | 560 | 35 | 8 | 21653829 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 7.54e-07 | 18 | 35 | 3 | 18834073 | |
| Pubmed | 7.96e-07 | 71 | 35 | 4 | 33541421 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 17203232 | ||
| Pubmed | Altered expression of MUC2 and MUC5AC in progression of colorectal carcinoma. | 9.84e-07 | 2 | 35 | 2 | 20731025 | |
| Pubmed | The complete genomic organization of the human MUC6 and MUC2 mucin genes. | 9.84e-07 | 2 | 35 | 2 | 15081123 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 35141985 | ||
| Pubmed | High-fat Diet Alters the Glycosylation Patterns of Duodenal Mucins in a Murine Model. | 9.84e-07 | 2 | 35 | 2 | 32141795 | |
| Pubmed | LRP1 is required for novobiocin-mediated fibronectin turnover. | 9.84e-07 | 2 | 35 | 2 | 30061663 | |
| Pubmed | MUC2 and MUC6 apomucins expression in human gastric neoplasm: an immunohistochemical analysis. | 9.84e-07 | 2 | 35 | 2 | 20878553 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 11445551 | ||
| Pubmed | Methylation status of promoters and expression of MUC2 and MUC5AC mucins in pancreatic cancer cells. | 9.84e-07 | 2 | 35 | 2 | 12527922 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 20101615 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 23832517 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 23832516 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 34968453 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 28321513 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 9422745 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 11988092 | ||
| Pubmed | Temporal analysis of goblet cells and mucin gene expression in murine models of allergic asthma. | 9.84e-07 | 2 | 35 | 2 | 14594655 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 30504806 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 11867643 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 12360467 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 12820724 | ||
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 17321686 | ||
| Pubmed | Induction of Gastric Cancer by Successive Oncogenic Activation in the Corpus. | 2.11e-06 | 25 | 35 | 3 | 34391772 | |
| Pubmed | 2.35e-06 | 214 | 35 | 5 | 22199357 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 22402132 | ||
| Pubmed | Secretory carcinoma of breast: pattern of MUC 2/MUC 4/MUC 6 expression. | 2.95e-06 | 3 | 35 | 2 | 23305535 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 19924550 | ||
| Pubmed | Gene expression profiling of colorectal mucinous adenocarcinomas. | 2.95e-06 | 3 | 35 | 2 | 20485009 | |
| Pubmed | Expression of aberrant mucins in lobular carcinoma with histiocytoid feature of the breast. | 2.95e-06 | 3 | 35 | 2 | 17333267 | |
| Pubmed | Mucin expression in reactive gastropathy: an immunohistochemical analysis. | 2.95e-06 | 3 | 35 | 2 | 17227128 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 28799085 | ||
| Pubmed | Differences in the expression of mucins in various forms of cystitis glandularis. | 2.95e-06 | 3 | 35 | 2 | 17659847 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 23828549 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 23464473 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 24920497 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 16447040 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 19718741 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 4.83e-06 | 248 | 35 | 5 | 24006456 | |
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 21596555 | ||
| Pubmed | Prognostic significance of CDX2 and mucin expression in small intestinal adenocarcinoma. | 5.90e-06 | 4 | 35 | 2 | 24603585 | |
| Pubmed | Interleukin-1beta induces MUC2 and MUC5AC synthesis through cyclooxygenase-2 in NCI-H292 cells. | 5.90e-06 | 4 | 35 | 2 | 12391274 | |
| Pubmed | Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly. | 5.90e-06 | 4 | 35 | 2 | 25034023 | |
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 25638393 | ||
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 23619266 | ||
| Pubmed | Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast. | 5.90e-06 | 4 | 35 | 2 | 22269464 | |
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 22691042 | ||
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 23283348 | ||
| Pubmed | [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors]. | 5.90e-06 | 4 | 35 | 2 | 17991319 | |
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 38462037 | ||
| Pubmed | 6.08e-06 | 118 | 35 | 4 | 21078624 | ||
| Pubmed | 9.69e-06 | 41 | 35 | 3 | 22675208 | ||
| Pubmed | Polymorphism of human mucin genes in chest disease: possible significance of MUC2. | 9.82e-06 | 5 | 35 | 2 | 11062147 | |
| Pubmed | pS2/TFF1 interacts directly with the VWFC cysteine-rich domains of mucins. | 9.82e-06 | 5 | 35 | 2 | 10611155 | |
| Pubmed | Semaphorin 7A promotes axon outgrowth through integrins and MAPKs. | 9.82e-06 | 5 | 35 | 2 | 12879062 | |
| Pubmed | 9.82e-06 | 5 | 35 | 2 | 12507512 | ||
| Pubmed | Differential expression of MUC genes in endometrial and cervical tissues and tumors. | 9.82e-06 | 5 | 35 | 2 | 16188033 | |
| Pubmed | 9.82e-06 | 5 | 35 | 2 | 24840470 | ||
| Pubmed | 9.82e-06 | 5 | 35 | 2 | 19047013 | ||
| Pubmed | 9.82e-06 | 5 | 35 | 2 | 12135769 | ||
| Pubmed | Apolipoprotein A-V interaction with members of the low density lipoprotein receptor gene family. | 9.82e-06 | 5 | 35 | 2 | 17326667 | |
| Pubmed | Laminin-10 and Lutheran blood group glycoproteins in adhesion of human endothelial cells. | 1.47e-05 | 6 | 35 | 2 | 16236823 | |
| Pubmed | 1.47e-05 | 6 | 35 | 2 | 16142311 | ||
| Pubmed | 1.47e-05 | 6 | 35 | 2 | 20874775 | ||
| Pubmed | 1.70e-05 | 153 | 35 | 4 | 25037231 | ||
| Pubmed | 2.06e-05 | 7 | 35 | 2 | 11891225 | ||
| Pubmed | 2.74e-05 | 8 | 35 | 2 | 15661641 | ||
| Pubmed | 3.39e-05 | 62 | 35 | 3 | 19367581 | ||
| Pubmed | 3.53e-05 | 9 | 35 | 2 | 17626061 | ||
| Pubmed | 3.53e-05 | 9 | 35 | 2 | 20005821 | ||
| Pubmed | 3.73e-05 | 64 | 35 | 3 | 22261194 | ||
| Pubmed | Tie2 regulates endocardial sprouting and myocardial trabeculation. | 4.47e-05 | 68 | 35 | 3 | 31112136 | |
| Pubmed | 4.81e-05 | 985 | 35 | 7 | 12975309 | ||
| Pubmed | SVEP1 is an endogenous ligand for the orphan receptor PEAR1. | 5.38e-05 | 11 | 35 | 2 | 36792666 | |
| Pubmed | Impaired angiogenesis and altered Notch signaling in mice overexpressing endothelial Egfl7. | 6.45e-05 | 12 | 35 | 2 | 20947685 | |
| Pubmed | Transmembrane semaphorin signalling controls laminar stratification in the mammalian retina. | 6.45e-05 | 12 | 35 | 2 | 21270798 | |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 6.87e-05 | 219 | 35 | 4 | 31353912 | |
| Pubmed | Conditional stabilization of beta-catenin expands the pool of lung stem cells. | 7.62e-05 | 13 | 35 | 2 | 18356571 | |
| Interaction | DUSP10 interactions | 6.82e-06 | 71 | 35 | 4 | int:DUSP10 | |
| Interaction | ZDHHC15 interactions | 6.36e-05 | 125 | 35 | 4 | int:ZDHHC15 | |
| Interaction | FBXO2 interactions | 6.82e-05 | 411 | 35 | 6 | int:FBXO2 | |
| Cytoband | 11p15.5 | 1.02e-04 | 118 | 35 | 3 | 11p15.5 | |
| GeneFamily | CD molecules|Mucins | 2.69e-06 | 21 | 24 | 3 | 648 | |
| GeneFamily | Prickle planar cell polarity proteins|LIM domain containing | 1.01e-05 | 4 | 24 | 2 | 1184 | |
| GeneFamily | Plexins | 6.05e-05 | 9 | 24 | 2 | 683 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 5.81e-04 | 27 | 24 | 2 | 1253 | |
| GeneFamily | LIM domain containing | 2.76e-03 | 59 | 24 | 2 | 1218 | |
| GeneFamily | Fibronectin type III domain containing | 1.89e-02 | 160 | 24 | 2 | 555 | |
| Coexpression | NABA_MATRISOME | PLXNA3 LAMB2 EYS LTBP2 EGFL7 FN1 MEGF6 IGFBP6 MUC2 SSPOP PLXNC1 MUC5AC MUC6 MEGF11 FBN3 SVEP1 WIF1 | 2.44e-15 | 1026 | 35 | 17 | M5889 |
| Coexpression | NABA_MATRISOME | PLXNA3 LAMB2 LTBP2 EGFL7 FN1 MEGF6 IGFBP6 MUC2 SSPOP PLXNC1 MUC5AC MUC6 MEGF11 SVEP1 WIF1 | 8.48e-13 | 1008 | 35 | 15 | MM17056 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.68e-10 | 196 | 35 | 8 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | 2.44e-09 | 275 | 35 | 8 | M5884 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.88e-07 | 191 | 35 | 6 | MM17059 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 3.88e-07 | 738 | 35 | 9 | MM17058 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 4.49e-07 | 751 | 35 | 9 | M5885 | |
| Coexpression | NABA_CORE_MATRISOME | 1.43e-06 | 270 | 35 | 6 | MM17057 | |
| Coexpression | NABA_ECM_AFFILIATED | 2.10e-06 | 158 | 35 | 5 | MM17063 | |
| Coexpression | NABA_ECM_AFFILIATED | 3.00e-06 | 170 | 35 | 5 | M5880 | |
| Coexpression | VANGURP_PANCREATIC_DELTA_CELL | 3.03e-06 | 75 | 35 | 4 | M45032 | |
| Coexpression | BROWNE_HCMV_INFECTION_48HR_DN | 3.87e-05 | 482 | 35 | 6 | M12144 | |
| Coexpression | GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_DN | 1.40e-04 | 199 | 35 | 4 | M5219 | |
| Coexpression | GSE13229_MATURE_VS_INTMATURE_NKCELL_UP | 1.43e-04 | 200 | 35 | 4 | M3213 | |
| Coexpression | GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_DN | 1.43e-04 | 200 | 35 | 4 | M5204 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HENDO | 1.47e-04 | 888 | 35 | 7 | M39049 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 1.50e-04 | 385 | 35 | 5 | M39264 | |
| Coexpression | DESCARTES_FETAL_STOMACH_GOBLET_CELLS | 2.05e-04 | 16 | 35 | 2 | M40303 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 2.61e-04 | 18 | 35 | 2 | M13796 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 2.61e-04 | 18 | 35 | 2 | MM1241 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_1 | 2.79e-04 | 440 | 35 | 5 | M39039 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP | 2.86e-04 | 96 | 35 | 3 | M5549 | |
| Coexpression | HEVNER_CORTEX_VASCULAR_ENDOTHELIAL_CELLS | 2.92e-04 | 19 | 35 | 2 | MM420 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 3.24e-04 | 20 | 35 | 2 | MM17053 | |
| Coexpression | MURARO_PANCREAS_DELTA_CELL | 3.35e-04 | 250 | 35 | 4 | M39170 | |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C2 | 3.58e-04 | 21 | 35 | 2 | M4767 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 3.95e-04 | 261 | 35 | 4 | M1834 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 4.12e-04 | 479 | 35 | 5 | M2573 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 4.28e-04 | 483 | 35 | 5 | MM1082 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 5.24e-04 | 505 | 35 | 5 | M39167 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_FBN1_FAP_CELLS | 5.79e-04 | 289 | 35 | 4 | M41750 | |
| Coexpression | TRAVAGLINI_LUNG_ADVENTITIAL_FIBROBLAST_CELL | 6.33e-04 | 296 | 35 | 4 | M41675 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_500_k-means-cluster#1 | 2.43e-05 | 219 | 34 | 5 | JC_hmvEC_500_K1 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_1000_k-means-cluster#4 | 5.40e-05 | 428 | 34 | 6 | JC_hmvEC_1000_K4 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 6.06e-05 | 437 | 34 | 6 | GSM777046_500 | |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | 7.12e-05 | 450 | 34 | 6 | GSM777063_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 7.57e-05 | 455 | 34 | 6 | GSM777055_500 | |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | 7.66e-05 | 456 | 34 | 6 | GSM777032_500 | |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | 7.94e-05 | 459 | 34 | 6 | GSM777037_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 8.63e-05 | 466 | 34 | 6 | GSM777050_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardioEndothel_top-relative-expression-ranked_500 | 1.20e-04 | 495 | 34 | 6 | PCBC_ctl_CardioEndothel_500 | |
| CoexpressionAtlas | geo_heart_top-relative-expression-ranked_2500_k-means-cluster#3 | 2.02e-04 | 183 | 34 | 4 | geo_heart_2500_K3 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 2.56e-04 | 361 | 34 | 5 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#4 | 3.06e-04 | 204 | 34 | 4 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000_K4 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 3.63e-04 | 87 | 34 | 3 | GSM777050_100 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_500_k-means-cluster#5 | 3.75e-04 | 88 | 34 | 3 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_500_K5 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 4.14e-04 | 91 | 34 | 3 | GSM777059_100 | |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | 4.84e-04 | 96 | 34 | 3 | GSM777063_100 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 4.99e-04 | 97 | 34 | 3 | GSM777046_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.95e-04 | 103 | 34 | 3 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_1000_k3 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_2500_k-means-cluster#1 | 5.99e-04 | 936 | 34 | 7 | JC_hmvEC_2500_K1 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 6.26e-04 | 439 | 34 | 5 | GSM777059_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 6.66e-04 | 445 | 34 | 5 | GSM777043_500 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 7.22e-04 | 453 | 34 | 5 | GSM777067_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardioEndothel_top-relative-expression-ranked_1000 | 7.77e-04 | 978 | 34 | 7 | PCBC_ctl_CardioEndothel_1000 | |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000 | 7.96e-04 | 982 | 34 | 7 | PCBC_ratio_MESO-5_vs_SC_1000 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000_k-means-cluster#1 | 8.04e-04 | 464 | 34 | 5 | JC_fibro_1000_K1 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_1000 | 8.35e-04 | 990 | 34 | 7 | JC_hmvEC_1000 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000 | 8.35e-04 | 990 | 34 | 7 | JC_fibro_1000 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-mesenchymal_stem_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.68e-09 | 190 | 35 | 6 | d13fd234caa3fc69d8a59bc0060cdacdf716ee55 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-08 | 200 | 35 | 6 | a4ec0e80f5422b91b85264a9bb74568dd577e285 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.28e-07 | 172 | 35 | 5 | 9a1743abcd5fbd38253ea84d88ad716cfb71de36 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-07 | 183 | 35 | 5 | 709a486154b3157427deb3b8886b63ac39ea42dd | |
| ToppCell | droplet-Liver-nan-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-07 | 183 | 35 | 5 | dc06f19f6f80f4c7f13f1f990c1fe0f91ba64ea7 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.27e-07 | 185 | 35 | 5 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-07 | 186 | 35 | 5 | a7ab70b049742dfe7ee30557031bfac6412edf52 | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-07 | 187 | 35 | 5 | 71385068e3fd0bfa7822ae176113a49460c8636b | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.45e-07 | 187 | 35 | 5 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-07 | 187 | 35 | 5 | e891e571f6bb9433a0046215de6cabd89ed1effc | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-07 | 190 | 35 | 5 | 38a815abf0ac5cac6071737cadc54a514f62d37d | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-07 | 190 | 35 | 5 | bb1476b44dd49e1dd52a636a91c4600b6d4fbe2e | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-07 | 190 | 35 | 5 | d180205c70b5ca9bc5a01a2e6cb42fcebc7f630d | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.93e-07 | 192 | 35 | 5 | 38d7a24ae205ef91ed2e0f402d8022f2a9cdb243 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.93e-07 | 192 | 35 | 5 | f88aba74d6e8c594c32fe2bc095b5da28b4b28e9 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.93e-07 | 192 | 35 | 5 | 04d155897ed075c359933080e36a4ab2150b6e9f | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.93e-07 | 192 | 35 | 5 | 2bfac6b3956265205ca47d06888851ed68b65999 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.93e-07 | 192 | 35 | 5 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.93e-07 | 192 | 35 | 5 | 41a8326cd5bc19ad5041068501bab4c72399222e | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.93e-07 | 192 | 35 | 5 | 84149a5c6c3b3c9b86aed77cf8e72d99ef099fab | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.93e-07 | 192 | 35 | 5 | 2d9e2262f1342fe17735f21f733c029d1275e955 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.93e-07 | 192 | 35 | 5 | d525f7f088a53110912600a7c9f6d33b9270d534 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 4.03e-07 | 193 | 35 | 5 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-07 | 193 | 35 | 5 | 45b5cab4dfeb0ed3b13631db5963740a792b810f | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.14e-07 | 194 | 35 | 5 | c8b9551b93a5aed62154b487db90130604a6125c | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 4.14e-07 | 194 | 35 | 5 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.14e-07 | 194 | 35 | 5 | 02b8102be9414d6964cd71019613edff6d88b893 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.14e-07 | 194 | 35 | 5 | 29f83cdd63314fff41258937d70b881a5503bfcc | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.14e-07 | 194 | 35 | 5 | d3db241ea316bbcde6d16618193b474591ad5ce4 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 4.14e-07 | 194 | 35 | 5 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | Monocytes-M2-like_CD16+_macrophages|World / Immune cells in Kidney/Urine in Lupus Nephritis | 4.24e-07 | 195 | 35 | 5 | 10fa47bdcf6c9784ea930b75a5861e139421feed | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-07 | 195 | 35 | 5 | 12ba6d95e42d06b1991b011043c0e3370a7b4131 | |
| ToppCell | (3)_Chondrocytes-(30)_Chondro|(3)_Chondrocytes / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.24e-07 | 195 | 35 | 5 | f5597d3ed37770c6fa2b339f98a80ac7ecd4f9ff | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 4.24e-07 | 195 | 35 | 5 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | (1)_Osterolineage_cells-(11)_OLC-2|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.24e-07 | 195 | 35 | 5 | 78978d85273e5463a7f43e4c121e647fa6aba42b | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.24e-07 | 195 | 35 | 5 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.24e-07 | 195 | 35 | 5 | 47762d9e442fb1f6f0033e3e10f4c6e498d2c081 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.35e-07 | 196 | 35 | 5 | 525d6c8a277364e624e7cc586275f8a891436b57 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.35e-07 | 196 | 35 | 5 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.35e-07 | 196 | 35 | 5 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.46e-07 | 197 | 35 | 5 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.46e-07 | 197 | 35 | 5 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.46e-07 | 197 | 35 | 5 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.58e-07 | 198 | 35 | 5 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.58e-07 | 198 | 35 | 5 | 05429f18e1d74880c1835568c86177f661b3477a | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.58e-07 | 198 | 35 | 5 | 306e28d31fd587409a12dcccc6b2abd7dc9c2e0a | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-07 | 198 | 35 | 5 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.69e-07 | 199 | 35 | 5 | 95d95e9b7bd3933188998ae94986213eb0f1e5ea | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.81e-07 | 200 | 35 | 5 | 933b5b400e48a511ba0a056be1d33d3610b5f10d | |
| ToppCell | 390C-Fibroblasts-Fibroblast-H-|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.81e-07 | 200 | 35 | 5 | ec7d6a08e34bcad5b3bbff56ebef96ae17e4cefd | |
| ToppCell | 343B-Fibroblasts|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.81e-07 | 200 | 35 | 5 | 376c1a77031e090be96948b47c78ac0d393f5775 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.81e-07 | 200 | 35 | 5 | db6281b5d4032116310db379d9175d790994c99c | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.81e-07 | 200 | 35 | 5 | cfea2f9d85646c9b722150551ff2e8fc4f6cc98a | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.81e-07 | 200 | 35 | 5 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.81e-07 | 200 | 35 | 5 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.81e-07 | 200 | 35 | 5 | 10f0c20ba7c71d9e2e177597f85b41cb40f0d878 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.81e-07 | 200 | 35 | 5 | f6be0f24e607abb9007823a54fb0b24d04990a89 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.81e-07 | 200 | 35 | 5 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Skin-Fibroblasts|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 4.81e-07 | 200 | 35 | 5 | f777eadf571a1a6d246da87346a9cb9d511c2e81 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.81e-07 | 200 | 35 | 5 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.81e-07 | 200 | 35 | 5 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_myofibroblast|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.81e-07 | 200 | 35 | 5 | 251fd2923f108cd2086961d897244b392c32ad54 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.81e-07 | 200 | 35 | 5 | 74ad0ae592252060ee294d7483327d765a6ba1dd | |
| ToppCell | tumor_Lung-Fibroblasts|tumor_Lung / Location, Cell class and cell subclass | 4.81e-07 | 200 | 35 | 5 | 073a68b5ce232203ffee86342cba2a00d907e119 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.81e-07 | 200 | 35 | 5 | fd92d8250c6ad1e8bb46b303ac37f8dcf80387d8 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.81e-07 | 200 | 35 | 5 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.81e-07 | 200 | 35 | 5 | a2bb67a06757f19be3f56f8cb5bb7e2affa5f4ed | |
| ToppCell | Fibroblast|World / shred by cell class for parenchyma | 4.81e-07 | 200 | 35 | 5 | dec9ce1bc2571197003596f32e5f742ede72aa79 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.81e-07 | 200 | 35 | 5 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | 390C-Fibroblasts-Fibroblast-H|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.81e-07 | 200 | 35 | 5 | 671e731977c58a0c44c36b56422085d93d999aad | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.81e-07 | 200 | 35 | 5 | 7ba292c30d915e66ebc8026fa76492cedf64700e | |
| ToppCell | Tracheal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.81e-07 | 200 | 35 | 5 | 920e6036c0a9c0089d0d898673daf9dd9d7279fc | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.81e-07 | 200 | 35 | 5 | 5a87bb8eb1c6bd2fbc357e1528e15ba1c0051438 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.33e-06 | 104 | 35 | 4 | 11d91471b6c4fa6b00a91d9fd4db72ee60d1f801 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.33e-06 | 104 | 35 | 4 | 424a58b04c8b5108b70f15d8353c8e4b9db1e730 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.33e-06 | 104 | 35 | 4 | 9b05ae514437eb0c8b1b23607ae8cbc371ffa85b | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-06 | 150 | 35 | 4 | 96b160f163030fbf48aedc37d6ae224e11492c52 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 7.22e-06 | 159 | 35 | 4 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-06 | 160 | 35 | 4 | 56e6f4b82b5dc41c45f9d253c2db314a6f702b84 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-06 | 160 | 35 | 4 | bb1b966fb9e801db15e67d03e49db4609d6f935a | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.59e-06 | 161 | 35 | 4 | 60f433eab9d5531bdf6aa86b0265f20b866b904c | |
| ToppCell | facs-Skin-nan-24m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.16e-06 | 164 | 35 | 4 | 7a65c7a6dbe5fb9067f83efafbb7ec8206d79325 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 8.16e-06 | 164 | 35 | 4 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 8.36e-06 | 165 | 35 | 4 | 7d319a112b9062efee428bef6f4534d2ce782e04 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.36e-06 | 165 | 35 | 4 | f80665b75d43f1bf6919d59fc762e7e0bac653f2 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.97e-06 | 168 | 35 | 4 | 06dc5b2d356d3a9454b10bba6f3b9ead2a0a7d46 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.97e-06 | 168 | 35 | 4 | 4b2d29a7843bf45922038c093ca7ec0600756adc | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.97e-06 | 168 | 35 | 4 | 1002f058a340763e3d8de0bd1f0547a903526ec6 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.40e-06 | 170 | 35 | 4 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | droplet-Spleen-nan-21m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.40e-06 | 170 | 35 | 4 | 03cb4e508356f85372a588c8d1c6babf2a012683 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.40e-06 | 170 | 35 | 4 | af8b56555cbd5a1016ab9ec2ce88225c58c89648 | |
| ToppCell | droplet-Spleen-nan-21m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.62e-06 | 171 | 35 | 4 | 9498c35b2a2c3a339dc8c5d49c8ec20d8ad52753 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.62e-06 | 171 | 35 | 4 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | droplet-Spleen-nan-21m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.62e-06 | 171 | 35 | 4 | db544252f98e073e5bb4bec4a110cd58e6434435 | |
| ToppCell | E12.5-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.84e-06 | 172 | 35 | 4 | ba99688e9f46671deccf824b1e77c6db0742d7df | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.84e-06 | 172 | 35 | 4 | a6fb1bde8d942c7b5caaf7bd14de0b7ce32fda55 | |
| ToppCell | E12.5-Endothelial-proliferative_endothelial_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.84e-06 | 172 | 35 | 4 | 2136170f6e1204734cec7dbf7b32e7d5179b92b5 | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Control / Condition, Lineage and Cell class | 1.03e-05 | 174 | 35 | 4 | 4c64ff5666812fb4efa440ba4faeca51d916d68e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-05 | 174 | 35 | 4 | 9c916af5eebd932f67dc9117e1d26ff194a2ff2c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-05 | 174 | 35 | 4 | bc71521f44a5fe013af42b06b5d1bd2446ecf3b5 | |
| Computational | Ovary genes. | 3.99e-05 | 368 | 20 | 6 | MODULE_1 | |
| Computational | DRG (dorsal root ganglia) genes. | 5.06e-05 | 384 | 20 | 6 | MODULE_2 | |
| Computational | Lung genes. | 1.00e-04 | 434 | 20 | 6 | MODULE_5 | |
| Computational | Spinal cord (neuro-development) genes. | 4.19e-04 | 360 | 20 | 5 | MODULE_12 | |
| Computational | Trachea genes. | 8.03e-04 | 415 | 20 | 5 | MODULE_6 | |
| Computational | Placenta genes. | 1.31e-03 | 463 | 20 | 5 | MODULE_38 | |
| Drug | Isoxsuprine hydrochloride [579-56-6]; Up 200; 11.8uM; PC3; HT_HG-U133A | 8.71e-06 | 184 | 35 | 5 | 4205_UP | |
| Drug | Etifenin [63245-28-3]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 1.13e-05 | 194 | 35 | 5 | 4117_UP | |
| Drug | Betahistine mesylate [54856-23-4]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 1.15e-05 | 195 | 35 | 5 | 2833_UP | |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 1.18e-05 | 196 | 35 | 5 | 6060_UP | |
| Drug | 4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid | 6.39e-05 | 8 | 35 | 2 | ctd:C064545 | |
| Drug | BM165 | 1.25e-04 | 11 | 35 | 2 | CID003352881 | |
| Drug | 3',4'-dihydroxyflavone | 1.25e-04 | 11 | 35 | 2 | ctd:C028288 | |
| Drug | 4-hydroxyretinoic acid | 1.50e-04 | 12 | 35 | 2 | ctd:C019429 | |
| Drug | pyrachlostrobin | 1.99e-04 | 811 | 35 | 7 | ctd:C513428 | |
| Drug | Rapamycin; Up 200; 0.1uM; PC3; HT_HG-U133A | 2.13e-04 | 193 | 35 | 4 | 4466_UP | |
| Drug | Novobiocin sodium salt [1476-53-5]; Up 200; 6.4uM; PC3; HT_HG-U133A | 2.13e-04 | 193 | 35 | 4 | 4569_UP | |
| Drug | Diltiazem hydrochloride [33286-22-5]; Up 200; 8.8uM; PC3; HT_HG-U133A | 2.18e-04 | 194 | 35 | 4 | 6710_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; HL60; HT_HG-U133A | 2.18e-04 | 194 | 35 | 4 | 6173_UP | |
| Drug | Chicago sky blue 6B [2610-05-1]; Up 200; 4uM; MCF7; HT_HG-U133A | 2.22e-04 | 195 | 35 | 4 | 4971_UP | |
| Drug | Cyclacillin [3485-14-1]; Up 200; 11.8uM; PC3; HT_HG-U133A | 2.22e-04 | 195 | 35 | 4 | 3800_UP | |
| Drug | (-) -Levobunolol hydrochloride [27912-14-7]; Up 200; 12.2uM; PC3; HT_HG-U133A | 2.22e-04 | 195 | 35 | 4 | 4016_UP | |
| Drug | Carbachol [51-83-2]; Up 200; 21.8uM; HL60; HT_HG-U133A | 2.26e-04 | 196 | 35 | 4 | 3042_UP | |
| Drug | (-)-Isoproterenol hydrochloride [5984-95-2]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 2.26e-04 | 196 | 35 | 4 | 3571_UP | |
| Drug | Methylhydantoin-5-(D) [55147-68-7]; Up 200; 35uM; PC3; HT_HG-U133A | 2.26e-04 | 196 | 35 | 4 | 3994_UP | |
| Drug | Asiaticoside [16830-15-2]; Up 200; 4.2uM; MCF7; HT_HG-U133A | 2.31e-04 | 197 | 35 | 4 | 3504_UP | |
| Drug | Citalopram hydrobromide [59729-32-7]; Down 200; 1uM; PC3; HT_HG-U133A | 2.31e-04 | 197 | 35 | 4 | 3820_DN | |
| Drug | Xamoterol hemifumarate [73210-73-8]; Down 200; 5uM; HL60; HT_HG-U133A | 2.31e-04 | 197 | 35 | 4 | 3064_DN | |
| Drug | Methylhydantoin-5-(D) [55147-68-7]; Down 200; 35uM; HL60; HT_HG-U133A | 2.31e-04 | 197 | 35 | 4 | 2994_DN | |
| Drug | Quinic acid [86-68-0]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 2.31e-04 | 197 | 35 | 4 | 3540_UP | |
| Drug | Vancomycin hydrochloride [1404-93-9]; Up 200; 2.6uM; PC3; HT_HG-U133A | 2.31e-04 | 197 | 35 | 4 | 4598_UP | |
| Drug | Arecoline hydrobromide [300-08-3]; Up 200; 17uM; MCF7; HT_HG-U133A | 2.31e-04 | 197 | 35 | 4 | 2657_UP | |
| Drug | Austricine [10180-88-8]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 2.31e-04 | 197 | 35 | 4 | 2812_UP | |
| Drug | Sulfameter [651-06-9]; Up 200; 14.2uM; HL60; HT_HG-U133A | 2.31e-04 | 197 | 35 | 4 | 2712_UP | |
| Drug | U-62066 [87151-85-7]; Up 200; 1uM; PC3; HT_HG-U133A | 2.35e-04 | 198 | 35 | 4 | 4553_UP | |
| Drug | Hydroflumethiazide [135-09-1]; Up 200; 12uM; HL60; HT_HG-U133A | 2.35e-04 | 198 | 35 | 4 | 1851_UP | |
| Drug | Practolol [6673-35-4]; Up 200; 15uM; PC3; HT_HG-U133A | 2.35e-04 | 198 | 35 | 4 | 4603_UP | |
| Drug | Tetramisole hydrochloride [16595-80-5]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 2.35e-04 | 198 | 35 | 4 | 2849_UP | |
| Drug | Oxprenolol hydrochloride [6452-73-9]; Up 200; 13.2uM; HL60; HT_HG-U133A | 2.35e-04 | 198 | 35 | 4 | 6145_UP | |
| Drug | Picrotoxinin [17617-45-7]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 2.35e-04 | 198 | 35 | 4 | 4842_UP | |
| Drug | Dosulepin hydrochloride [897-15-4]; Up 200; 12uM; MCF7; HT_HG-U133A | 2.40e-04 | 199 | 35 | 4 | 5986_UP | |
| Drug | Meprylcaine hydrochloride [956-03-6]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 2.40e-04 | 199 | 35 | 4 | 3544_UP | |
| Drug | Lysergol [602-85-7]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 2.44e-04 | 200 | 35 | 4 | 4966_UP | |
| Drug | Pivmecillinam hydrochloride [32887-03-9]; Up 200; 8.4uM; PC3; HT_HG-U133A | 2.44e-04 | 200 | 35 | 4 | 7312_UP | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 1.40e-08 | 5 | 34 | 3 | DOID:3030 (is_marker_for) | |
| Disease | cystitis (is_marker_for) | 1.29e-06 | 2 | 34 | 2 | DOID:1679 (is_marker_for) | |
| Disease | sputum mucin-5B amount | 3.86e-06 | 3 | 34 | 2 | OBA_2050332 | |
| Disease | bringing up phlegm, sputum or mucus on most days, self-reported | 4.62e-05 | 9 | 34 | 2 | EFO_0009824 | |
| Disease | cholangiocarcinoma (is_marker_for) | 5.55e-05 | 64 | 34 | 3 | DOID:4947 (is_marker_for) | |
| Disease | homostachydrine measurement | 9.97e-05 | 13 | 34 | 2 | EFO_0021164 | |
| Disease | gastric ulcer (implicated_via_orthology) | 1.16e-04 | 14 | 34 | 2 | DOID:10808 (implicated_via_orthology) | |
| Disease | caffeine measurement | 1.34e-04 | 15 | 34 | 2 | EFO_0021177 | |
| Disease | ischemia (biomarker_via_orthology) | 1.95e-04 | 18 | 34 | 2 | DOID:326 (biomarker_via_orthology) | |
| Disease | peak expiratory flow | 2.49e-04 | 498 | 34 | 5 | EFO_0009718 | |
| Disease | urinary bladder cancer (is_marker_for) | 2.56e-04 | 107 | 34 | 3 | DOID:11054 (is_marker_for) | |
| Disease | adult onset asthma | 3.41e-04 | 118 | 34 | 3 | EFO_1002011 | |
| Disease | ferritin measurement | 3.49e-04 | 119 | 34 | 3 | EFO_0004459 | |
| Disease | systemic mastocytosis | 3.80e-04 | 25 | 34 | 2 | MONDO_0016586 | |
| Disease | renal cell carcinoma (is_marker_for) | 4.32e-04 | 128 | 34 | 3 | DOID:4450 (is_marker_for) | |
| Disease | colorectal cancer, overall survival | 5.13e-04 | 29 | 34 | 2 | EFO_0000638, MONDO_0005575 | |
| Disease | respiratory system disease | 6.22e-04 | 145 | 34 | 3 | EFO_0000684 | |
| Disease | pneumonia | 1.35e-03 | 47 | 34 | 2 | EFO_0003106 | |
| Disease | Crohn Disease | 1.52e-03 | 50 | 34 | 2 | C0010346 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.68e-03 | 447 | 34 | 4 | EFO_0000694, MONDO_0100096 | |
| Disease | cystic fibrosis (is_marker_for) | 2.33e-03 | 62 | 34 | 2 | DOID:1485 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KSCTGRCWGPTENHC | 191 | Q15303 | |
| GRCRCPAGWRGDTCQ | 121 | Q9UHF1 | |
| GNNHQESPGWRCCRP | 106 | Q96KE9 | |
| HNGCRHGTCSTPWQC | 256 | Q9NR61 | |
| FCRNGGTWENGRCIC | 51 | Q96K78 | |
| RASCCCSLGRAWGNP | 1516 | Q75N90 | |
| CSRGRWACQQGTHCP | 851 | Q6W4X9 | |
| DHWGPHCSNRCQCQN | 136 | A6BM72 | |
| HCTPGWTGLFCTQRC | 726 | A6BM72 | |
| VPWCAHHLCRNNGTC | 2336 | Q5T1H1 | |
| CWEHCRNGGTCAASP | 4236 | Q07954 | |
| PRFNCGWCISEHRCQ | 801 | P51805 | |
| HCGWCHSLQRCTFQG | 471 | O60486 | |
| RGRWVCTQAVCHGTC | 846 | Q02817 | |
| CDRCQRGQWGFPSCR | 861 | P55268 | |
| GCWQHISCNFPGCRT | 81 | Q969J5 | |
| CTCSGGRWSCQEVPC | 416 | P98088 | |
| GLGACWHPQCFVCTT | 206 | O43900 | |
| QRCWHQPCFACQACG | 106 | Q2TBC4 | |
| TCFGGQRGWRCDNCR | 2411 | P02751 | |
| RNVCGGQCCPGWTTA | 166 | Q14767 | |
| CRSSQGQRRGPCWCV | 201 | P24592 | |
| TCCINSHCGWPRGKD | 6 | Q6PGQ1 | |
| CQRACDTGHWGPDCS | 856 | O75095 | |
| CRNGHCIPQRWACDG | 1206 | Q92673 | |
| VCVCRGRQWHCTGQR | 996 | A2VEC9 | |
| WHGGPCRVCQCLHNL | 1981 | A2VEC9 | |
| VRPNHTCCWTYCGNI | 61 | Q8NEX5 | |
| CVRPNRCHCLSSWTG | 3546 | Q4LDE5 | |
| WGRRCSFRCNCHGSP | 186 | Q14162 | |
| PCHKGSWCSSNQLCR | 351 | Q7RTX1 | |
| AWHRCSSCGQAFGQR | 211 | Q86XF7 | |
| GLGRGCHRNCVTTTW | 1941 | Q9NY15 | |
| GRCTLDQNGWHCVCQ | 751 | Q9P273 | |
| CQCQEGWHGRHCNKR | 326 | Q9Y5W5 | |
| QWGRCVTCQRCGPGQ | 11 | Q9HAV5 | |
| PNCTEHCRCWPGSRV | 1111 | Q9Y493 | |
| HCRCWPGSRVECQIS | 1116 | Q9Y493 |